At Google’s I/O Developer Conference last month, MediSafe expanded its medication management platform to include wearables, becoming the first mobile health app on Google’s just-announced suite of Android Wear smartwatches, the company announced Tuesday.
Verizon is expanding its mobile health solutions portfolio with the launch of its new Verizon Virtual Visits, which is designed to provide an easy, convenient and cost-effective way for patients to be seen remotely by a clinician for a cold, flu, sore throat or other simple, acute condition via video on their smartphone, tablet or computer.
The digital movement is no doubt revolutionizing the retail landscape as it has given rise to e-commerce, complexities to the path to purchase, shifts between planned and unplanned purchases, and changes to store trips. To remain competitive, retailers must develop new strategies and grasp the importance of an “omni-perspective.”
According to a survey released Wednesday by Retale, a location-based shopping platform aggregating weekly circulars from more than 60 top-line retailers for mobile and digital devices, 71% of mobile app users say they don't like the idea of being tracked into a store via their smartphones, and 56% say they are not interested in receiving push notifications while shopping.
In what appears to be a marketing first, natural personal care brand Burt’s Bees is reportedly introducing promotional messages that appear as appointments in electronic calendars on computers, smartphones and tablets, according to a New York Times article.
A new study released by mobile engagement provider Mobiquity has found that while 70% of people use mobile apps on a daily basis to track calorie intake and monitor physical activities, only 40% share data and insights with their doctors.
The month of March saw a steep rise in smartphone-generated traffic, orders, and revenue by consumers to retailer smartphone-optimized websites over the year-ago period, according to mobile commerce platform Branding Brand.
Beauty retailer Sephora has unveiled its new Beauty Board, a social shopping platform to engage shoppers through beauty images and allow them to post, share, browse and shop Sephora’s photo gallery directly on the retailer's web site, the mobile site, iPhone and Android apps.
It's finally happening. Pfizer has placed the ball at the line of scrimmage. And based on the X's and O's to come out of its Lipitor OTC actual-use study, Pfizer will be making its run with its eye on the ultimate prize — a successful Rx-to-OTC switch of a statin. Only this time, the Food and Drug Administration may not be as quick to sack Pfizer's switch attempt. With the advances and pervasion of health technology in the self-care space by way of smartphones and tablets; with the evolution of the pharmacist as a healthcare professional able to practice at the top of their license; and with the adoption of diagnostic tests like a cholesterol panel that can be physically administered in the pharmacy, consumers may finally get it right when self-selecting a statin. Because it's the consumer actual-use studies that have scuttled just about every statin switch attempt in the past. In the last switch of Mevacor, FDA advisory panelists determined the statin was safe enough for the self-care space. And it was effective. It's just that the consumers who would be right for an OTC statin didn't appropriately self-select. And if they can't appropriately self-select, what's the point, really?